147 related articles for article (PubMed ID: 28576000)
1. The effect of solvents and hydrophilic additive on stable coating and controllable sirolimus release system for drug-eluting stent.
Kim SM; Park SB; Bedair TM; Kim MH; Park BJ; Joung YK; Han DK
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():39-46. PubMed ID: 28576000
[TBL] [Abstract][Full Text] [Related]
2. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.
Bedair TM; Yu SJ; Im SG; Park BJ; Joung YK; Han DK
J Colloid Interface Sci; 2015 Dec; 460():189-99. PubMed ID: 26319336
[TBL] [Abstract][Full Text] [Related]
3. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
Choi J; Jang BN; Park BJ; Joung YK; Han DK
Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
[TBL] [Abstract][Full Text] [Related]
4. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
Bedair TM; Kang SN; Joung YK; Han DK
J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating.
Kim SM; Park KS; Lih E; Hong YJ; Kang JH; Kim IH; Jeong MH; Joung YK; Han DK
Acta Biomater; 2016 Jul; 38():143-52. PubMed ID: 27109766
[TBL] [Abstract][Full Text] [Related]
6. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymer brush as nanocoupled interface for improving the durability of polymer coating on metal surface.
Bedair TM; Cho Y; Joung YK; Han DK
Colloids Surf B Biointerfaces; 2014 Oct; 122():808-817. PubMed ID: 25200098
[TBL] [Abstract][Full Text] [Related]
8. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus.
Su LC; Chen YH; Chen MC
ACS Appl Mater Interfaces; 2013 Dec; 5(24):12944-53. PubMed ID: 24294944
[TBL] [Abstract][Full Text] [Related]
9. Drug loaded nanoparticle coating on totally bioresorbable PLLA stents to prevent in-stent restenosis.
Zhao J; Mo Z; Guo F; Shi D; Han QQ; Liu Q
J Biomed Mater Res B Appl Biomater; 2018 Jan; 106(1):88-95. PubMed ID: 27875036
[TBL] [Abstract][Full Text] [Related]
10. Optimized polymer coating for magnesium alloy-based bioresorbable scaffolds for long-lasting drug release and corrosion resistance.
Xu W; Yagoshi K; Koga Y; Sasaki M; Niidome T
Colloids Surf B Biointerfaces; 2018 Mar; 163():100-106. PubMed ID: 29284158
[TBL] [Abstract][Full Text] [Related]
11. Preparation and optimization of media using Pluronic® micelles for solubilization of sirolimus and release from the drug eluting stents.
Raval A; Parmar A; Raval A; Bahadur P
Colloids Surf B Biointerfaces; 2012 May; 93():180-7. PubMed ID: 22265756
[TBL] [Abstract][Full Text] [Related]
12. Study of drug-eluting coating on metal coronary stent.
Shanshan C; Lili T; Yingxue T; Bingchun Z; Ke Y
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1476-80. PubMed ID: 23827598
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dextran-based sirolimus-eluting stents and PLA-based sirolimus-eluting stents in vitro and in vivo.
Lee SY; Bae IH; Park DS; Jang EJ; Shim JW; Lim KS; Park JK; Sim DS; Jeong MH
J Biomed Mater Res A; 2017 Jan; 105(1):301-310. PubMed ID: 27615559
[TBL] [Abstract][Full Text] [Related]
14. Sustained drug release using cobalt oxide nanowires for the preparation of polymer-free drug-eluting stents.
Bedair TM; Min IJ; Park W; Joung YK; Han DK
J Biomater Appl; 2018 Sep; 33(3):352-362. PubMed ID: 30223735
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
[TBL] [Abstract][Full Text] [Related]
16. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents.
Indolfi L; Causa F; Giovino C; Ungaro F; Quaglia F; Netti PA
J Biomed Mater Res A; 2011 May; 97(2):201-11. PubMed ID: 21394898
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
18. Technical overview on the MiStent coronary stent.
McCLAIN JB; Carlyle WC; Donohoe DJ; Ormiston JA
Minerva Cardioangiol; 2016 Oct; 64(5):560-71. PubMed ID: 27152624
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co-Cr substrates for prevention of initial in-stent restenosis.
Lih E; Jung JW; Joung YK; Ahn DJ; Han DK
Colloids Surf B Biointerfaces; 2016 Apr; 140():353-360. PubMed ID: 26774572
[TBL] [Abstract][Full Text] [Related]
20. The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence.
Chisari A; Pistritto AM; Piccolo R; La Manna A; Danzi GB
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
